Aggramed Injection

Aggramed Injection contains Tirofiban HCL as its active component. It is an antiplatelet agent used to prevent or treat conditions related to abnormal blood clotting, particularly when there is a high risk of thrombosis. It is frequently used alongside PCI (angioplasty) to help prevent blood clot formation during the procedure. This medication may sometimes be used to manage thrombocytopenia, a condition characterised by low platelet counts.

Patients with known hypersensitivity or allergy to Aggramed Injection or any of its components should not receive this medication. As a potent antiplatelet medication, it is contraindicated in patients with active bleeding disorders or active bleeding episodes. It is generally contraindicated in patients with a history of haemorrhagic stroke, as it may increase the risk of recurrent bleeding in the brain and is typically avoided in these individuals. Patients who have undergone major surgical procedures or experienced significant trauma within the previous six weeks may be at higher risk of bleeding complications with this medication and may be considered contraindicated.

This medication should be used with caution in patients with kidney problems, and dosage adjustment may be necessary. Individuals with known bleeding disorders or conditions that increase bleeding risk, such as haemophilia or von Willebrand disease, should generally not receive this medication. It may increase the risk of bleeding in the brain, so it is typically contraindicated in patients with known intracranial neoplasms or aneurysms.

The medication can be used in elderly patients but requires caution, as they may be more prone to bleeding due to age-related physiological changes. Aggramed Injection is typically not used in children, as its safety and efficacy in paediatric populations have yet to be well established.

Aggramed Injection is used in the following: Acute coronary syndromes (ACS) Percutaneous coronary intervention (PCI) Thrombocytopenia management Ischemic stroke Coronary artery bypass grafting (CABG) Adjunctive treatment (high-risk patients).

Aggramed Injection works by inhibiting the glycoprotein IIb/IIIa receptor on the surface of platelets. This receptor plays a crucial role in platelet aggregation and clot formation. By blocking this receptor, tirofiban helps prevent the formation of blood clots.

Aggramed Injection causes some side effects like all medications, although not everyone will experience them. Serious Bleeding Thrombocytopenia Allergic reactions Low blood pressure Back pain or chest Pain Common Bleeding at the injection site Nausea Headache Fever Pain or swelling at the injection site Chest discomfort or tightness.

Aggramed Injection should be used with caution as it may increase the risk of bleeding. Patients with bleeding disorders, recent surgery, or a tendency to bleed easily should be extra careful. Regular monitoring is required for allergic reactions, low blood pressure, and platelet counts. Kidney and liver function should be checked during treatment. Be cautious of drug interactions, especially with blood thinners. Pregnant or breastfeeding individuals should consult their doctor before use. Platelet function and cardiac monitoring may be needed during treatment. Always know the location of the nearest emergency medical facility. Ensure the drug is given through proper IV administration.